THE LANCET:
More about fluoride
DIRECTORY:
FAN
>
Health
>
Cancer
>
NTP
Study > News
THE LANCET
September 22, 1990
USA: More about fluoride
by J.B. Sibbison
Early this year Newsweek
magazine published a story with this advice for readers: "Brush
your teeth, but the fluoride from your tap may not do much good
- and may cause cancer". The supporting cancer hazard evidence
was an animal study sponsored by the government's National
Toxicology Program (Lancet, Feb 3, p282). Since then, the
Public Health Service has responded to this and similar news
stories by reaffirming its confidence in the safety and effectiveness
of fluoridated drinking water. The NTP findings, said the PHS,
were too equivocal to conclude otherwise. The headlines stopped.
The scientific debate, however, goes on. On Aug 28 William
L. Marcus, chief toxicologist for the Environmental Protection
Agency's drinking water programme, claimed that the original
findings of the NTP study showed the cancer hazard from fluoridated
drinking water to be greater than the NTP was telling the public.
His analysis was presented, without endorsement from the EPA,
to the American Chemical Society's 200th biannual meeting in
Washington.
Judging from Dr Marcus' presentation, this is a case of a disagreement
among scientists. The original study was directed from 1985
to 1987 by Dr John D. Toft II, manager of the pathology section
at Battelle Memorial Institute in Columbus, Ohio. The Battelle
study's principal finding was the occurrence of an extremely
rare liver cancer, hepatocholangiocarcinoma, in male and female
mice. In 1989, the NTP asked Experimental Pathology Laboratories,
of Sterling, Virginia, to review Battelle's data. At this point,
the liver cancer finding, along with a diagnosis of metaplastic
and precancerous cells in the mouths of rats, was downgraded.
The only effect of fluoride that was left after these reclassifications
and still another review by a board of pathologists and others
was osteosarcoma. Dr
Marcus believes the Battelle diagnosis of liver cancers was
sound and should have been included in the NTP report. This,
he says, would change "the (NTP) equivocal finding... to
at least some evidence or clear evidence of carcinogenicity".
NTP's failure to emphasize another finding also figured in
Dr Marcus' critique. Three out of four in-vitro tests, he says,
proved fluoride to be mutagenic, "supporting the conclusion
that fluoride is a probable human carcinogen". A careful
reader can find this information in the text of the report,
but the authors make no mention of these data in their conclusions.
As the next step, Dr Marcus wants the EPA to conduct an independent
review of the NTP study. The agency, however, wants to wait
for the completion of a literature search by a Health and Human
Services panel headed by Dr Frank Young, a former Commissioner
of the Food and Drug Administration. What may rank with equal
importance in the public mind to the possibility of hazard is
the question of effectiveness.
The National Institute
of Dental Research's latest estimate is that children in
fluoridated areas have 18% fewer cavities than those drinking
untreated water.
John Yiamouyiannis,
a biochemist and antifluoridation leader, has analysed NIDR's
data and says the advantage is 5% at the most. Keeping in mind
that a full set of teeth has 128 surfaces, he says, that means
the disadvantage for children drinking unfluoridated water will
be, on the average, additional decay in less than one of those
surfaces.